This is a randomized, double-blind, placebo-controlled, multicenter, parallel-group study in adult and adolescent subjects with moderate-to-severe AD. Eligible subjects must have a documented history of inadequate response to topical AD …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 12 and above
TRIAL STATUS: Active, not recruiting
Youth aged 12 to 17 with a history of eczema (atopic dermatitis) for at least one year, may qualify to participate in this study. Adolescents must have moderate to severe …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 12 to 17 years
TRIAL STATUS: Active, not recruiting
Title: A non-interventional, prospective 12 months study to characterize the REAL-life effectiveness and treatment patterns of Secukinumab and current standard of care in patient with chronic plaque psoriAsis eligible for …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Active, not recruiting
